Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical Management and Therapeutic Strategy of Uterine Sarcoma According to Histological Subtype and Staging: Updated Review and Recommendations.

Cancers·2026
Same author

Nonvascularized Iliac Crest Autograft for Wrist and Hand Reconstructions: A Report of Two Clinical Cases and Literature Review.

Journal of orthopaedic case reports·2026
Same author

Appendicular Soft Tissue Sarcoma Surgery in the Era of Orthoplastics.

Cancers·2026
Same author

ASO Visual Abstract: Consensus Guidelines on Perioperative Care in Primary Retroperitoneal Sarcoma Surgery.

Annals of surgical oncology·2026
Same author

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

JAMA network open·2026
Same author

Differentiating Upper Tract Urothelial Carcinoma with Synchronous or Metachronous Bladder Cancer.

Current issues in molecular biology·2026

Related Experiment Video

Updated: Oct 30, 2025

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.6K

Sarcoma Metabolomics: Current Horizons and Future Perspectives.

Miguel Esperança-Martins1,2,3, Isabel Fernandes1,3,4, Joaquim Soares do Brito4,5

  • 1Centro Hospitalar Universitário Lisboa Norte, Medical Oncology Department, Hospital Santa Maria, 1649-028 Lisboa, Portugal.

Cells
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Cancer cells reprogram energy metabolism for growth. This review details the metabolomics of soft tissue and bone sarcomas, aiming to improve diagnosis and identify new therapeutic targets for patients.

Keywords:
bone sarcomagastrointestinal stromal tumormetabolismmetabolomicssarcomasoft tissue sarcoma

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.2K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.0K

Related Experiment Videos

Last Updated: Oct 30, 2025

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.6K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.2K
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

6.0K

Area of Science:

  • Oncology
  • Metabolomics
  • Cancer Biology

Background:

  • Cancer cells exhibit diverse metabolic adaptations supporting biosynthesis, energy demands, and redox balance.
  • Reprogramming of energy metabolism is crucial for cancer cell proliferation.
  • The metabolome of soft tissue and bone sarcomas is not well-characterized.

Purpose of the Study:

  • To review the current understanding of cancer metabolomics.
  • To explore recent findings on the metabolomics of soft tissue and bone sarcomas.
  • To highlight the potential for diagnostic and therapeutic advancements in sarcoma treatment.

Main Methods:

  • Literature review of cancer metabolomics.
  • Detailed analysis of recent studies on soft tissue and bone sarcoma metabolomics.
  • Synthesis of current knowledge on sarcoma metabolic landscape.

Main Results:

  • Cancer cells extensively modify their metabolism to fuel proliferation and survival.
  • Significant gaps exist in the detailed understanding of sarcoma metabolic profiles.
  • Emerging metabolomic data offers insights into sarcoma heterogeneity.

Conclusions:

  • Understanding cancer cell metabolic reprogramming is vital for cancer research.
  • Further characterization of sarcoma metabolomics is essential for clinical applications.
  • Metabolomic insights may lead to novel diagnostic tools and therapeutic strategies for sarcomas.